美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
50383-287-93	50383-287	HUMAN PRESCRIPTION DRUG	Buprenorphine and Naloxone	buprenorphine hydrochloride and naloxone hydrochloride	TABLET	SUBLINGUAL	20160107	20250331	ANDA	ANDA204431	Akorn Operating Company LLC (dba Akorn)	BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE	8 mg/1; 2 mg/1	30 TABLET in 1 BOTTLE, PLASTIC (50383-287-93)
0121-1018-30	0121-1018	HUMAN PRESCRIPTION DRUG	Buprenorphine and Naloxone	buprenorphine hydrochloride and naloxone hydrochloride	TABLET	SUBLINGUAL	20230905	N/A	ANDA	ANDA204431	PAI Holdings, LLC dba Pharmaceutical Associates, Inc. and dba PAI Pharma	BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE	2 mg/1; .5 mg/1	30 TABLET in 1 BOTTLE, PLASTIC (0121-1018-30)
50383-294-93	50383-294	HUMAN PRESCRIPTION DRUG	Buprenorphine and Naloxone	buprenorphine hydrochloride and naloxone hydrochloride	TABLET	SUBLINGUAL	20160107	20250331	ANDA	ANDA204431	Akorn Operating Company LLC (dba Akorn)	BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE	2 mg/1; .5 mg/1	30 TABLET in 1 BOTTLE, PLASTIC (50383-294-93)
0121-2036-30	0121-2036	HUMAN PRESCRIPTION DRUG	Buprenorphine and Naloxone	buprenorphine hydrochloride and naloxone hydrochloride	TABLET	SUBLINGUAL	20230905	N/A	ANDA	ANDA204431	PAI Holdings, LLC dba Pharmaceutical Associates, Inc. and dba PAI Pharma	BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE	8 mg/1; 2 mg/1	30 TABLET in 1 BOTTLE, PLASTIC (0121-2036-30)